Cargando…
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
Anaplastic thyroid cancer (ATC) is a rare and lethal human malignancy with no known effective therapies in the majority of cases. Despite the use of conventional treatments such as chemotherapy, radiation and surgical resection, this disease remains almost universally fatal. In the present study, we...
Autores principales: | Pinto, Nicole, Prokopec, Stephenie D., Vizeacoumar, Frederick, Searle, Karlee, Lowerison, Matthew, Ruicci, Kara M., Yoo, John, Fung, Kevin, MacNeil, Danielle, Lacefield, Jim C., Leong, Hon S., Mymryk, Joe S., Barrett, John W., Datti, Alessandro, Boutros, Paul C., Nichols, Anthony C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231667/ https://www.ncbi.nlm.nih.gov/pubmed/30419054 http://dx.doi.org/10.1371/journal.pone.0207152 |
Ejemplares similares
-
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
por: Pinto, Nicole, et al.
Publicado: (2020) -
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
por: Ghasemi, Farhad, et al.
Publicado: (2017) -
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
por: Ghasemi, Farhad, et al.
Publicado: (2018) -
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
por: Ruicci, Kara M., et al.
Publicado: (2020) -
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
por: Mundi, Neil, et al.
Publicado: (2019)